AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12057728 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of necrotic blastomeres from all partially damaged embryos
Number of subjects: 235
Study 10480153 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO3) given five minutes before meals
Number of subjects: 12
Study 10480153 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CaCO3) given during meals
Number of subjects: 12
Study 8607671 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day admission
Number of subjects: 276
Study 1932450 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination with 4 x 100 g polymyxin E, 4 x 80 mg tobramycin and 4 x 500 mg amphotericin B administered through the gastric tube and with an antimicrobial sticky paste in the oropharynx (group I)
Number of subjects: 40
Study 1932450 — intervention group
Group type: COMPARATOR
Intervention: 50 mg of polymyxin B and 80 mg of gentamicin dissolved in 10 ml of 0.9% saline at 6 h intervals into nose, oropharynx and stomach as well as 300 mg of amphotericin B in the oropharynx only (group II)
Number of subjects: 40
Study 6757842 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 52
Study 6757842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 31586639 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (D3 B.O.N®), 200,000 IU at 1 month and 200,000 IU at 6 months
Number of subjects: 150
Study 31586639 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-supplemented children)
Number of subjects: 150
Study 31085285 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram developed from MA.20 trial data
Number of subjects: 1832
Study 31085285 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram validated externally
Number of subjects: 1832
Study 31085285 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 1832
Study 31085285 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of axillary surgery
Number of subjects: 1832
Study 31085285 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of nodal irradiation
Number of subjects: 1832
Study 29194851 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin 8% patch
Number of subjects: 488
Study 29194851 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 488
Study 26434665 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2963016 insulin glargine (LY IGlar)
Number of subjects: 1291
Study 26434665 — intervention group
Group type: COMPARATOR
Intervention: Lantus® insulin glargine (IGlar)
Number of subjects: 1291
Study 26434665 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior IGlar subgroup of patients with T2DM
Number of subjects: 1291
Study 25103657 — intervention group
Group type: EXPERIMENTAL
Intervention: 30°C OVDs
Number of subjects: 4
Study 25103657 — intervention group
Group type: COMPARATOR
Intervention: Room temperature OVDs
Number of subjects: 4
Study 25103657 — intervention group
Group type: EXPERIMENTAL
Intervention: 26°C
Number of subjects: 4
Study 25103657 — intervention group
Group type: EXPERIMENTAL
Intervention: 32°C
Number of subjects: 4
Study 21960113 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal/chest/arm advanced pneumatic compression therapy
Number of subjects: 42
Study 21960113 — intervention group
Group type: COMPARATOR
Intervention: Arm only pneumatic compression
Number of subjects: 42
Study 21960113 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 19960145 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic intervention (physician contact with supervisor and occupational physiotherapist ergonomic assessment)
Number of subjects: 177
Study 19960145 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ergonomic intervention)
Number of subjects: 177
Study 18632412 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC group, n = 21)
Number of subjects: 41
Study 18632412 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CsA group, n = 20)
Number of subjects: 41
Study 16199745 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback together with academic detailing and practice guidelines
Number of subjects: 20
Study 16199745 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback together with seminars and practice guidelines
Number of subjects: 20
Study 16199745 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback alone
Number of subjects: 20
Study 12243636 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1326
Study 12243636 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 1326
Study 10473005 — intervention group
Group type: EXPERIMENTAL
Intervention: Mapping-enhanced counseling
Number of subjects: 381
Study 10473005 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 381
Study 8938897 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanolamine oleate
Number of subjects: 78
Study 8938897 — intervention group
Group type: COMPARATOR
Intervention: Absolute ethanol
Number of subjects: 78
Study 2010437 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (85‐325 mg daily up to or within 48 hours of surgery)
Number of subjects: 100
Study 2010437 — intervention group
Group type: COMPARATOR
Intervention: No aspirin (discontinued at least 4 days before surgery)
Number of subjects: 100
Study 7104563 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (NS)
Number of subjects: 184
Study 7104563 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol/dextropropoxyphene (control)
Number of subjects: 184
Study 29556866 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5672 (experimental compound)
Number of subjects: 0
Study 29556866 — intervention group
Group type: EXPERIMENTAL
Intervention: LQMM method
Number of subjects: 0
Study 29556866 — intervention group
Group type: EXPERIMENTAL
Intervention: Bootstrap CI calculation methods
Number of subjects: 0
Study 26655857 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing process-based simulation training program
Number of subjects: 49
Study 26655857 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods of training for maternal and child emergency nursing care
Number of subjects: 49
Study 24332324 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive lornoxicam 8 mg intravenously 25 minutes before surgery
Number of subjects: 43
Study 24332324 — intervention group
Group type: COMPARATOR
Intervention: Postoperative lornoxicam
Number of subjects: 43
Study 22804901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate analysis in SGA fetuses
Number of subjects: 1496
Study 22804901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate analysis in AGA fetuses
Number of subjects: 1496
Study 22804901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate analysis in LGA fetuses
Number of subjects: 1496
Study 22804901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate analysis in SGA fetuses with lactacidaemia
Number of subjects: 1496
Study 22804901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate analysis in AGA fetuses with lactacidaemia
Number of subjects: 1496
Study 22804901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate analysis in LGA fetuses with lactacidaemia
Number of subjects: 1496
Study 22804901 — intervention group
Group type: COMPARATOR
Intervention: Cord artery pH < 7.00
Number of subjects: 1496
Study 22804901 — intervention group
Group type: COMPARATOR
Intervention: Metabolic acidaemia
Number of subjects: 1496
Study 22804901 — intervention group
Group type: COMPARATOR
Intervention: Apgar score <7 at 5 minutes
Number of subjects: 1496
Study 20175406 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone 2 mg
Number of subjects: 388
Study 20175406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study 17115388 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release levodopa (IR LD)
Number of subjects: 14
Study 17115388 — intervention group
Group type: COMPARATOR
Intervention: Controlled-release levodopa (not specified if used in this context)
Number of subjects: 14
Study 15625351 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium 1000 mg/day
Number of subjects: 45
Study 15625351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 12212876 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed local anesthetic solution (37 degrees C)
Number of subjects: 44
Study 12212876 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature local anesthetic solution (21 degrees C)
Number of subjects: 44
Study 9469393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 49
Study 9469393 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 49
Study 9469393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil (after crossover)
Number of subjects: 49
Study 9469393 — intervention group
Group type: COMPARATOR
Intervention: Penicillin (after crossover)
Number of subjects: 49
Study 8597874 — intervention group
Group type: EXPERIMENTAL
Intervention: rBPI23 (1 mg/kg)
Number of subjects: 8
Study 8597874 — intervention group
Group type: COMPARATOR
Intervention: Placebo (human serum albumin, 0.2 mg/kg)
Number of subjects: 8
Study 2698046 — intervention group
Group type: EXPERIMENTAL
Intervention: methylprednisolone (mPSL)
Number of subjects: 100
Study 2698046 — intervention group
Group type: EXPERIMENTAL
Intervention: antilymphocyte globulin (ALG)
Number of subjects: 100
Study 2698046 — intervention group
Group type: EXPERIMENTAL
Intervention: antithymocytoglobulin (ATG)
Number of subjects: 100
Study 1211323 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation programme
Number of subjects: 0
Study 1211323 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30253725 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive pharmacist intervention at the beginning of oral antineoplastic therapy
Number of subjects: 200
Study 30253725 — intervention group
Group type: COMPARATOR
Intervention: Nurse-led control group
Number of subjects: 200
Study 30253725 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 200
Study 30253725 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pharmacist and nurse-led)
Number of subjects: 200
Study 27903559 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-specific message with enhanced active choice (EAC)
Number of subjects: 3665
Study 27903559 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-specific message alone
Number of subjects: 3665
Study 27903559 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3665
Study 24856027 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular end‐diastolic pressure‐guided volume expansion (n=196)
Number of subjects: 396
Study 24856027 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid administration protocol (Control group, n=200)
Number of subjects: 396
Study 22382482 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentralized clinical pharmacy services (CPOMS)
Number of subjects: 1129
Study 22382482 — intervention group
Group type: COMPARATOR
Intervention: Centralized registered nurse management (comparison group)
Number of subjects: 1129
Study 20715601 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprinkles micronutrient powders
Number of subjects: 550
Study 18772724 — intervention group
Group type: EXPERIMENTAL
Intervention: Balafilcon A (PureVision) lens
Number of subjects: 22
Study 18772724 — intervention group
Group type: COMPARATOR
Intervention: Galyfilcon A (Acuvue Advance) lens
Number of subjects: 22
Study 16631046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral cefuroxime
Number of subjects: 24
Study 16631046 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative topical levofloxacin
Number of subjects: 24
Study 16631046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 14960217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted support (conferences, dissemination of manuals, support from trained non-physicians during outreach visits)
Number of subjects: 617
Study 14960217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted support
Number of subjects: 617
Study 14960217 — intervention group
Group type: COMPARATOR
Intervention: No special attention (control group)
Number of subjects: 617
Study 11105102 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousing story
Number of subjects: 46
Study 11105102 — intervention group
Group type: COMPARATOR
Intervention: Neutral story
Number of subjects: 46
Study 8629932 — intervention group
Group type: EXPERIMENTAL
Intervention: Tehlin knee
Number of subjects: 28
Study 8629932 — intervention group
Group type: COMPARATOR
Intervention: 3R20 knee
Number of subjects: 28
Study 7910321 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 436
Study 7910321 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (mitomycin, doxorubicin, and fluorouracil)
Number of subjects: 436
Study 7910321 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 436
Study 3213065 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxium (calcium dobesilate) 1000 mg (2 x 1 capsule) daily for 8 weeks (2 weeks preoperatively and 6 weeks postoperatively)
Number of subjects: 120
Study 3213065 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 120
Study 30945151 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 500 mg once daily for 6 months postoperatively
Number of subjects: 189
Study 28532702 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 35 mg twice daily for 72 hours, starting 48 hours before the procedure, in addition to isotonic saline hydration.
Number of subjects: 100
Study 28532702 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline hydration only (control group).
Number of subjects: 100
Study 28532702 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine 35 mg twice daily for 72 hours, starting 48 hours before the procedure, in conjunction with isotonic saline hydration.
Number of subjects: 100
Study 27883324 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (50 μg transdermal oestradiol, 5 mg MPA)
Number of subjects: 15
Study 27883324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 23246272 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with 5-fluorouracil (57% of patients)
Number of subjects: 285
Study 23246272 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy without 5-fluorouracil
Number of subjects: 285
Study 23246272 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 285
Study 20671103 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose-containing dialysis solution (group A)
Number of subjects: 23
Study 20671103 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level GDP fluid (group B)
Number of subjects: 23
Study 20671103 — intervention group
Group type: COMPARATOR
Intervention: Residual renal function (RRF) in group A
Number of subjects: 23
Study 20671103 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual renal function (RRF) in group B
Number of subjects: 23
Study 19777463 — intervention group
Group type: COMPARATOR
Intervention: Treatment
Number of subjects: 0
Study 19777463 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 17075233 — intervention group
Group type: EXPERIMENTAL
Intervention: Italian version of the Body Cathexis Scale (BCS)
Number of subjects: 490
Study 15603207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 60 mg/pseudoephedrine HCl 120 mg
Number of subjects: 486
Study 15603207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 486
Study 11282902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sibrafiban plus aspirin (LDS+A)
Number of subjects: 6671
Study 11282902 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose sibrafiban (HDS)
Number of subjects: 6671
Study 11282902 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 6671
Study 8777774 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (1.5 mg/kg)
Number of subjects: 49
Study 8777774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 2042259 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxylapatite
Number of subjects: 104
Study 2042259 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate
Number of subjects: 104
Study 2042259 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiel bone
Number of subjects: 104
Study 2042259 — intervention group
Group type: COMPARATOR
Intervention: Control (empty iliac crest)
Number of subjects: 104
Study 6386897 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate mouthwash (5 ml twice daily for 4 weeks, containing 5 mg folate per 5 ml)
Number of subjects: 60
Study 6386897 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 60
Study 30545576 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day decitabine schedule
Number of subjects: 71
Study 30545576 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day decitabine schedule
Number of subjects: 71
Study 28419379 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of local anesthetic to a peripheral pain generator (MTrP or other discrete tender point)
Number of subjects: 31
Study 28419379 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 31
Study 28419379 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of local anesthetic
Number of subjects: 31
Study 25667151 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention targeting identified characteristics of frailty and problems identified during geriatric assessment for 12 months.
Number of subjects: 230
Study 25667151 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 230
Study 23619321 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 200
Study 23619321 — intervention group
Group type: COMPARATOR
Intervention: Multiport laparoscopic cholecystectomy (4PLC)
Number of subjects: 200
Study 21801750 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning methods using Support Vector Machines (SVMs) for eye movement analysis during the Visual Paired Comparison (VPC) task.
Number of subjects: 0
Study 21801750 — intervention group
Group type: COMPARATOR
Intervention: Novelty preference information (traditional method).
Number of subjects: 0
Study 19479072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (including physical activity, weight reduction, and dietary counseling)
Number of subjects: 522
Study 19479072 — intervention group
Group type: COMPARATOR
Intervention: Control group (mini-intervention)
Number of subjects: 522
Study 17704988 — intervention group
Group type: EXPERIMENTAL
Intervention: WS 5570 600 mg/day
Number of subjects: 161
Study 17704988 — intervention group
Group type: EXPERIMENTAL
Intervention: WS 5570 1200 mg/day
Number of subjects: 161
Study 17704988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 14676561 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia (group 2)
Number of subjects: 3
Study 14676561 — intervention group
Group type: COMPARATOR
Intervention: Combined propofol-clonidine anesthesia (group 3)
Number of subjects: 3
Study 14676561 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and clonidine (group 3)
Number of subjects: 3
Study 11423999 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (5 microg/kg/d) after PBPC transplantation at day 1
Number of subjects: 123
Study 11423999 — intervention group
Group type: COMPARATOR
Intervention: No G-CSF administration
Number of subjects: 123
Study 11423999 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of > 5 x 10(6)/kg CD34+ cells
Number of subjects: 123
Study 11423999 — intervention group
Group type: COMPARATOR
Intervention: Infusion of ≤ 5 x 10(6)/kg CD34+ cells
Number of subjects: 123
Study 11423999 — intervention group
Group type: COMPARATOR
Intervention: Patients with BM involvement
Number of subjects: 123
Study 11423999 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without BM involvement
Number of subjects: 123
Study 11423999 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF administration
Number of subjects: 123
Study 9668370 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐1 ganglioside
Number of subjects: 797
Study 9668370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 797
Study 8873964 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, non-strenuous, weight-lifting exercise program (performed once a week at the medical facility and twice a week on their own)
Number of subjects: 96
Study 8873964 — intervention group
Group type: COMPARATOR
Intervention: Free physical activity (control group)
Number of subjects: 96
Study 8873964 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading and nonstrenuous strengthening exercises
Number of subjects: 96
Study 2675700 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled atropine sulfate
Number of subjects: 60
Study 2675700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 769527 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (200 mg/day for 2 months)
Number of subjects: 27
Study 769527 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (320 mg/day for 2 months)
Number of subjects: 27
Study 769527 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of spironolactone and propranolol at half dosage
Number of subjects: 27
Study 769527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 30888705 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory control training
Number of subjects: 0
Study 30888705 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory training
Number of subjects: 0
Study 30888705 — intervention group
Group type: COMPARATOR
Intervention: Control training condition
Number of subjects: 0
Study 28258263 — intervention group
Group type: EXPERIMENTAL
Intervention: Upbeat music distraction group
Number of subjects: 60